13: NAMPT mRNA Transfection
- Page ID
- 221317
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\( \newcommand{\dsum}{\displaystyle\sum\limits} \)
\( \newcommand{\dint}{\displaystyle\int\limits} \)
\( \newcommand{\dlim}{\displaystyle\lim\limits} \)
\( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)
( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\id}{\mathrm{id}}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\kernel}{\mathrm{null}\,}\)
\( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\)
\( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\)
\( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)
\( \newcommand{\vectorA}[1]{\vec{#1}} % arrow\)
\( \newcommand{\vectorAt}[1]{\vec{\text{#1}}} % arrow\)
\( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vectorC}[1]{\textbf{#1}} \)
\( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)
\( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)
\( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\(\newcommand{\longvect}{\overrightarrow}\)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\(\newcommand{\ket}[1]{\left| #1 \right>}\)
\(\newcommand{\bra}[1]{\left< #1 \right|}\)
\(\newcommand{\braket}[2]{\left< #1 \vphantom{#2} \right| \left. #2 \vphantom{#1} \right>}\)
\(\newcommand{\braopket}[3]{\left< #1 \vphantom{#2}\vphantom{#3} \right| #2 \vphantom{#1}\vphantom{#3} \left| #3 \vphantom{#1}\vphantom{#2} \right>}\)
\(\newcommand{\qmvec}[1]{\mathbf{\vec{#1}}}\)
\(\newcommand{\op}[1]{\hat{\mathbf{#1}}}\)
\(\newcommand{\expect}[1]{\langle #1 \rangle}\)
\(\newcommand{\dfn}[1]{\emph{\textbf{#1}}}\)
- Explain how lipid reagents help deliver mRNA into cells.
- Distinguish transient mRNA expression from plasmid DNA expression.
- Identify controls and measurements needed to evaluate a transfection.
BACKGROUND
Transfection (introducing nucleic acids into cells) allows us to change what cells make and then observe the result. Messenger RNA (mRNA) (an RNA copy of genetic instructions that a cell can translate into protein) gives the cell a template for making a specific protein. In this exercise, the introduced mRNA carries instructions for making NAMPT. This is different from small interfering RNA (siRNA) (a short RNA molecule used to reduce the amount of a selected mRNA). Supplying NAMPT mRNA is intended to increase the opportunity to make NAMPT protein; an siRNA experiment is generally designed to reduce expression of its target.
Mesenchymal stromal cells (MSCs) (cells grown in culture that can form several connective tissue cell types) receive mRNA encoding NAMPT (nicotinamide phosphoribosyltransferase, an enzyme that helps recycle nicotinamide to make NAD⁺). NAD⁺ (nicotinamide adenine dinucleotide, a molecule used in many cellular energy and repair reactions) is important to cell function. An increase in NAMPT protein might affect this pathway, but the outcome must be measured: adding mRNA alone does not establish that the protein or NAD⁺ level increased.
RNA is easily broken down outside cells, and its size and electrical charge make it difficult to pass directly through the cell membrane. A lipid transfection reagent (a preparation of fat-like molecules that helps deliver nucleic acids into cells) is mixed with mRNA to form mRNA–lipid complexes (particles containing both the mRNA and the delivery reagent). Following the reagent instructions for mixing order, amount, and waiting time helps the complexes form reproducibly. After the complexes enter cells, mRNA that reaches the cytoplasm (the region of the cell outside the nucleus) can be read by ribosomes (cell structures that build proteins from mRNA instructions). Delivery can vary between wells and can stress cells, so record cell appearance and viability (the proportion of cells that remain alive).
Expression from introduced mRNA is generally transient (lasting for a limited time), because the mRNA is gradually degraded and does not ordinarily become part of the cell’s DNA. Plasmid DNA (a circular DNA molecule that can carry a gene) follows a different route: it must reach the nucleus (the compartment containing the cell’s chromosomes) before the cell can transcribe it into mRNA. Plasmid expression may also be temporary; plasmid delivery alone does not show that DNA integrated into the genome. The treatment and measurement times matter because RNA, protein, and downstream effects may reach their highest levels at different times.
Controls help separate the effect of the NAMPT sequence from the effect of the delivery process. A control mRNA (an mRNA chosen for comparison that does not encode NAMPT) helps show how cells respond to receiving mRNA and lipid. Reagent-only wells (cells exposed to lipid reagent without mRNA) can reveal effects of the delivery reagent, while untreated wells show the culture’s baseline condition. Replicates (independently prepared wells receiving the same treatment) help show whether a result is consistent. Use the assigned assay to measure NAMPT RNA, and measure NAMPT protein separately if the class has a validated protein assay. A high RNA signal does not prove protein production, and a change in NAD⁺ alone does not identify its cause. Compare each result with its matched control and consider changes in cell number or viability.
MATERIALS
- MSCs
- Six-well culture plates
- NAMPT mRNA
- Lipid reagent suitable for mRNA transfection and MSCs
- Medium specified by the transfection reagent instructions
- Antibiotic-free culture medium
- Complete culture medium
- Appropriate control mRNA and untreated or reagent-only controls
- Cell culture equipment
- Materials for cell viability and NAMPT expression measurements
METHODS
1. Using the class cell plating procedure, seed MSCs in labeled six-well plates with the assigned volume of medium. Plan for the cells to reach the confluence range specified for the selected mRNA reagent on transfection day. Record cell passage, plating density, and well IDs.
2. Make a well map that assigns NAMPT mRNA, an appropriate control mRNA, and untreated or reagent-only controls as directed. Include replicates. Write down the planned sampling times and assays before preparing mixtures.
3. Read the selected transfection reagent instructions for the mRNA amount, lipid amount, dilution medium, and final culture volume for a six-well plate. Calculate the amounts needed for all assigned wells plus the approved pipetting allowance. Dilute mRNA and lipid separately, and prepare matched control mixtures the same way.
4. Combine the diluted mRNA with the diluted lipid reagent in the order specified for that product. Allow the mRNA-lipid complexes to form for the stated time. Record the preparation and addition times.
5. Inspect the MSCs for healthy appearance and the required confluence. Change the medium only if directed by the reagent procedure. Add the assigned mixture to each labeled well, distribute it gently, and record the actual amounts. Keep all wells at the assigned final culture volume.
6. Return the plate to its assigned incubator conditions. Observe the cells at the planned time and change medium if the reagent and cell-specific procedure requires it. Record cell appearance and any signs of stress.
7. At the planned collection time, measure cell viability and collect samples using the separate assay procedures. RT-qPCR measures NAMPT RNA, while an immunoassay or immunoblot can measure NAMPT protein if validated for this experiment. If NAD⁺ is measured, record it as a separate outcome. Compare each measurement with the appropriate control and account for cell number or viability when required by the assay.
EXERCISE NAMPT mRNA Transfection NAME____________________________
EXPECTATIONS
1. Predict how NAMPT RNA and NAMPT protein measurements might compare between NAMPT mRNA wells and control mRNA wells if delivery and translation succeed.
2. Predict how a large decrease in cell viability could complicate your interpretation even if NAMPT RNA appears higher in treated wells.
RESULTS
Complete the record below and attach the well map and assay data. Report NAMPT RNA, NAMPT protein, and NAD⁺ as separate measurements when available. Show how each treated result was compared with its matched control.
Culture and transfection plan
Student: ____________________ Partner: ____________________ Date: __________
MSC identity/source: __________ Passage: ______ Plating density and units: ______
Plate ID: __________ Plating date/time: __________ Confluence (%): ______
mRNA ID/lot: __________ Lipid reagent/lot: __________ Medium/lot: __________
Reagent instruction reference: __________ Incubator conditions: __________
Planned sampling times and assays: _______________________________________
Record units and actual observations. Use N/A for measurements not performed.
Six well treatment map
|
Well |
Treatment / control |
Replicate |
Sample ID |
|
A1 |
|
|
|
|
A2 |
|
|
|
|
A3 |
|
|
|
|
B1 |
|
|
|
|
B2 |
|
|
|
|
B3 |
|
|
|
Mixture preparation
|
Treatment |
mRNA amount and units |
Lipid (µL) |
Dilution medium (µL) |
Final well volume (mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfection and assay results
Student: ____________________ Partner: ____________________ Date: __________
Complex preparation time: ______ Complex formation interval: ______
Mixture addition time: ______ Medium change time or N/A: ______
Assay method/units: RNA __________ Protein __________ NAD⁺ __________
Normalization method and matched control: ________________________________
Record units and actual observations. Use N/A for measurements not performed.
Culture observations
|
Well / sample ID |
Date / time after addition |
Medium / appearance |
Viability (%) |
Collection time |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate assay results
|
Sample / replicate |
Matched control ID |
NAMPT RNA / units |
NAMPT protein / units |
NAD⁺ / units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Calculations and observations
Show reagent amounts for all assigned wells and the approved pipetting allowance. Show how each measured result was normalized, if required, and compared with its matched control. Attach raw assay data and calculations.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Observations deviations and corrective actions
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Raw assay data / attachment IDs: __________________________________________
CONCLUSIONS
1. What evidence supports delivery of NAMPT mRNA? What additional evidence would show that the cells produced more NAMPT protein?
2. Did transfection affect cell viability? How does that affect your interpretation of the NAMPT results?
3. If NAD⁺ was measured, did it change along with NAMPT protein? Explain what these measurements do and do not establish. If NAD⁺ was not measured, explain what conclusion remains open.
4. Which control was most useful for interpreting your results, and why?